Viking Therapeutics Inc (VKTX) USD0.00001

Sell:$32.57Buy:$32.99$0.85 (2.70%)

Prices delayed by at least 15 minutes
Sell:$32.57
Buy:$32.99
Change:$0.85 (2.70%)
Prices delayed by at least 15 minutes
Sell:$32.57
Buy:$32.99
Change:$0.85 (2.70%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
6 January 2025
Brian LianChairman/CEO
Sell
Tax related
175,490$42.69$7,491,457.512,385,570
6 January 2025
Brian LianChairman/CEO
Sell
Tax related
19,000$43.32$823,068.602,366,570
6 January 2025
Marianna ManciniCOO
Sell
Tax related
49,115$42.69$2,096,660.41379,234
6 January 2025
Marianna ManciniCOO
Sell
Tax related
5,100$43.32$220,928.94374,134
6 January 2025
Greg ZanteCFO
Sell
Tax related
45,609$42.69$1,946,993.48169,959
6 January 2025
Greg ZanteCFO
Sell
Tax related
4,700$43.32$203,601.18165,259
8 November 2024
Lawson MacartneyChairman of the Board
Sell
Option/Award related
2,000$68.67$137,333.4047,965
28 October 2024
Greg ZanteCFO
Sell
Option/Award related
49,672$74.56$3,703,494.65231,381
28 October 2024
Greg ZanteCFO
Sell
Option/Award related
18,620$75.79$1,411,135.32212,761
28 October 2024
Greg ZanteCFO
Sell
Option/Award related
9,265$76.94$712,802.78203,496

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
1 March 2024
Brian LianChairman/CEO
Sell
Tax related
162,815$85.22$13,875,094.302,198,734
27 March 2024
Brian LianChairman/CEO
Sell
Tax related
153,948$83.34$12,830,026.322,266,453
1 May 2024
Marianna ManciniCOO
Sell
Option/Award related
119,946$79.29$9,511,058.10354,756
20 September 2024
Brian LianChairman/CEO
Sell
Option/Award related
119,874$71.15$8,529,047.092,305,127
1 May 2024
Marianna ManciniCOO
Sell
Option/Award related
105,343$78.65$8,284,974.13474,702

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.